Naloxone is an opioid receptor antagonist that rapidly reverses or blocks the effects of opioids, restores normal respiration and heart rhythm, and reverses the potentially fatal effects of an overdose. Although naloxone is included in U.S. CDC recommendations, the drug is currently prescribed to less than 1 in 70 patients prescribed high-dose opioid prescriptions. Researchers propose a call to action for all health providers and state medical societies to ensure the widest distribution and easy availability of naloxone, including over the counter, which is likely to be FDA-approved very soon.
Tag: prescription opioids
History of traumatic brain injury linked to higher rates of prescription opioid use and misuse
Adults with a history of traumatic brain injury (TBI), even years previously, are at increased risk of use and misuse of prescription opioid medications, reports a study in the September/October special issue of the Journal of Head Trauma Rehabilitation (JHTR).
New Diagnostic Method May Predict Relapse Risk for Those Recovering from Prescription Opioid Addiction
Rutgers scientists have used a diagnostic technique for the first time in the opioid addiction field that they believe has the potential to determine which opioid-addicted patients are more likely to relapse.